Lista de obras -

A multimeric L2 vaccine for prevention of animal papillomavirus infections.

artículo científico publicado en 2011

B cell memory: building two walls of protection against pathogens

scientific article published on 13 December 2019

B cell signaling in context

scientific article published on 08 July 2019

Capsomer vaccines protect mice from vaginal challenge with human papillomavirus

artículo científico publicado en 2011

Efficacy of RG1-VLP vaccination against infections with genital and cutaneous human papillomaviruses.

scientific article published on 10 May 2013

Expression of inhibitory receptors by B cells in chronic human infectious diseases restricts responses to membrane-associated antigens

artículo científico publicado en 2020

Impact of inhibitors and L2 antibodies upon the infectivity of diverse alpha and beta human papillomavirus types

artículo científico publicado en 2014

Intrinsic properties of human germinal center B cells set antigen affinity thresholds

scientific article published on 01 November 2018

Multivalent human papillomavirus l1 DNA vaccination utilizing electroporation

artículo científico publicado en 2013

Murine skin and vaginal mucosa are similarly susceptible to infection by pseudovirions of different papillomavirus classifications and species

artículo científico publicado en 2012

Optimization of multimeric human papillomavirus L2 vaccines

artículo científico publicado en 2013

Phylogenetic considerations in designing a broadly protective multimeric L2 vaccine

artículo científico publicado en 2013

Preparation and properties of a papillomavirus infectious intermediate and its utility for neutralization studies

artículo científico publicado en 2013

Prevention of cancer by prophylactic human papillomavirus vaccines

artículo científico publicado en 2010

Production of Furin-Cleaved Papillomavirus Pseudovirions and Their Use for In Vitro Neutralization Assays of L1- or L2-Specific Antibodies

artículo científico publicado en 2015

Roles of Fc domain and exudation in L2 antibody-mediated protection against human papillomavirus.

artículo científico publicado en 2018

Seroepidemiology of Human Papillomavirus 16 (HPV16) L2 and Generation of L2-Specific Human Chimeric Monoclonal Antibodies

artículo científico publicado en 2015

The high risk HPV16 L2 minor capsid protein has multiple transport signals that mediate its nucleocytoplasmic traffic

artículo científico publicado en 2011

Vaccination with multimeric L2 fusion protein and L1 VLP or capsomeres to broaden protection against HPV infection

artículo científico publicado en 2010

Lista de obras de

A multimeric L2 vaccine for prevention of animal papillomavirus infections.

B cell memory: building two walls of protection against pathogens

B cell signaling in context

Capsomer vaccines protect mice from vaginal challenge with human papillomavirus

Efficacy of RG1-VLP vaccination against infections with genital and cutaneous human papillomaviruses.

Expression of inhibitory receptors by B cells in chronic human infectious diseases restricts responses to membrane-associated antigens

Impact of inhibitors and L2 antibodies upon the infectivity of diverse alpha and beta human papillomavirus types

Intrinsic properties of human germinal center B cells set antigen affinity thresholds

Multivalent human papillomavirus l1 DNA vaccination utilizing electroporation

Murine skin and vaginal mucosa are similarly susceptible to infection by pseudovirions of different papillomavirus classifications and species

Optimization of multimeric human papillomavirus L2 vaccines

Phylogenetic considerations in designing a broadly protective multimeric L2 vaccine

Preparation and properties of a papillomavirus infectious intermediate and its utility for neutralization studies

Prevention of cancer by prophylactic human papillomavirus vaccines

Production of Furin-Cleaved Papillomavirus Pseudovirions and Their Use for In Vitro Neutralization Assays of L1- or L2-Specific Antibodies

Roles of Fc domain and exudation in L2 antibody-mediated protection against human papillomavirus.

Seroepidemiology of Human Papillomavirus 16 (HPV16) L2 and Generation of L2-Specific Human Chimeric Monoclonal Antibodies

The high risk HPV16 L2 minor capsid protein has multiple transport signals that mediate its nucleocytoplasmic traffic

Vaccination with multimeric L2 fusion protein and L1 VLP or capsomeres to broaden protection against HPV infection